← Back to headlines
AbbVie and Genmab Secure EU Label Expansion for Cancer Drug Tepkinly
AbbVie and Genmab have received approval for an EU label expansion for their drug Tepkinly, specifically for the treatment of follicular lymphoma.
7 Jul, 16:38 — 7 Jul, 16:38
Sources
Showing 1 of 1 sources
